av/taro-pharmaceutical-industries--big.svg

NYSE:TARO

Taro Pharmaceutical Industries Ltd.

  • Stock

USD

Last Close

42.97

21/06 19:59

Market Cap

1.62B

Beta: 0.70

Volume Today

147.06K

Avg: 16.05K

PE Ratio

34.88

PFCF: 18.53

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '14
Mar '15
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
Mar '23
Mar '24
average inventory
113.63M
-
118.96M
4.68%
129.41M
8.79%
139.80M
8.03%
142.82M
2.16%
146.34M
2.46%
150.58M
2.90%
166.68M
10.70%
195.37M
17.21%
218.55M
11.87%
215.74M
1.29%
average payables
211.27M
-
275.21M
30.27%
277.28M
0.75%
227.65M
17.90%
117.77M
48.27%
30.38M
74.20%
31.96M
5.20%
45.01M
40.84%
64.70M
43.74%
68.36M
5.66%
56.57M
17.24%
average receivables
270.37M
-
387.25M
43.23%
491.34M
26.88%
489.77M
0.32%
399.81M
18.37%
307.36M
23.12%
278.05M
9.54%
268.84M
3.31%
286.79M
6.68%
283.08M
1.29%
218.47M
22.83%
book value per share
22.94
-
32.96
43.70%
45.09
36.80%
50.06
11.03%
54.92
9.70%
48.87
11.01%
54.70
11.93%
44.59
18.49%
45.47
1.98%
46.05
1.29%
47.71
3.59%
capex per share
-0.58
-
-0.47
20.13%
-0.45
4.17%
-0.87
94.08%
-0.74
15.04%
-0.79
6.99%
-0.74
6.19%
-0.45
39.22%
-0.32
28.72%
-0.47
48.46%
capex to depreciation
-1.56
-
-1.26
18.97%
-1.29
1.96%
-2.41
87.38%
-1.79
25.74%
-1.65
7.85%
-1.33
19.52%
-0.72
45.48%
-0.46
35.83%
-0.56
19.58%
capex to operating cash flow
-0.07
-
-0.05
32.07%
-0.05
1.35%
-0.08
69.00%
-0.09
11.66%
-0.09
3.88%
-0.10
10.28%
-0.37
258.31%
0.08
120.25%
-0.56
840.97%
capex to revenue
-0.03
-
-0.02
32.01%
-0.02
13.02%
-0.04
102.33%
-0.04
9.75%
-0.05
2.65%
-0.04
3.86%
-0.03
29.08%
-0.02
31.33%
-0.03
45.24%
cash per share
14.28
-
21.48
50.43%
28.68
33.55%
33.58
17.06%
35.43
5.51%
26.91
24.04%
28.83
7.12%
26.79
7.07%
21.80
18.61%
22.62
3.75%
23.40
3.42%
days of inventory on hand
239.51
-
235.56
1.65%
294.39
24.97%
247.35
15.98%
266.01
7.54%
241.11
9.36%
228.01
5.43%
260.81
14.39%
286.36
9.80%
271.59
5.16%
230.59
15.10%
days payables outstanding
491.33
-
605.39
23.21%
521.55
13.85%
367.98
29.44%
47.27
87.15%
57.09
20.76%
42.98
24.70%
88.48
105.85%
92.85
4.93%
82.06
11.62%
50.28
38.72%
days sales outstanding
144.77
-
200.21
38.29%
195.54
2.33%
195.16
0.19%
181.65
6.92%
155.45
14.42%
153.29
1.39%
177.45
15.76%
199.42
12.38%
165.30
17.11%
102.95
37.72%
debt to assets
0.01
-
0.00
75.64%
-0.03
930.04%
-0.02
16.09%
-0.00
90.63%
0.01
394.18%
-0.00
116.90%
-0.00
63.09%
0.00
349.48%
-0.00
161.08%
debt to equity
0.02
-
0.00
76.29%
-0.03
864.02%
-0.03
17.98%
-0.00
90.66%
0.01
398.76%
-0.00
116.78%
-0.00
53.15%
0.00
324.56%
-0.00
159.26%
dividend yield
0.12
-
earnings yield
0.07
-
0.08
9.32%
0.09
9.98%
0.09
7.47%
0.05
43.31%
0.07
23.58%
0.10
56.33%
-0.14
237.05%
0.04
125.16%
0.03
22.21%
0.03
21.92%
enterprise value
4.72B
-
5.57B
17.84%
5.56B
0.11%
4.22B
24.16%
3.35B
20.43%
3.68B
9.63%
1.84B
49.92%
2.21B
20.23%
1.38B
37.71%
761.52M
44.79%
1.22B
60.77%
enterprise value over ebitda
10.62
-
11.28
6.25%
8.91
21.04%
8.27
7.10%
9.43
13.98%
13.04
38.24%
7.28
44.17%
3.04
58.21%
6.56
115.69%
14.46
120.47%
39.37
172.25%
ev to operating cash flow
13.20
-
13.68
3.60%
14.07
2.84%
9.64
31.51%
10.36
7.55%
11.36
9.63%
6.78
40.31%
48.38
613.45%
-8.69
117.97%
23.98
375.94%
ev to sales
6.22
-
6.45
3.69%
5.85
9.34%
4.79
18.00%
5.07
5.71%
5.49
8.33%
2.86
47.97%
4.03
41.21%
2.46
39.08%
1.33
45.91%
1.95
46.40%
free cash flow per share
7.49
-
9.03
20.50%
8.78
2.80%
9.73
10.81%
7.33
24.70%
7.52
2.59%
6.32
15.86%
0.75
88.15%
-4.54
705.46%
0.37
108.16%
free cash flow yield
0.07
-
0.06
5.16%
0.06
4.30%
0.08
36.12%
0.07
10.30%
0.07
7.75%
0.10
49.70%
0.01
90.17%
-0.10
1,132.19%
0.02
114.51%
graham net net
14.75
-
23.69
60.62%
33.36
40.83%
38.59
15.68%
37.83
1.97%
28.55
24.54%
30.08
5.36%
15.77
47.57%
18.36
16.42%
20.05
9.21%
29.45
46.89%
graham number
64.81
-
91.56
41.28%
113.19
23.62%
111.56
1.44%
80.61
27.75%
89.15
10.59%
88.41
0.83%
102.57
16.02%
39.79
61.20%
26.49
33.44%
39.22
48.09%
income quality
0.99
-
0.84
15.34%
0.73
12.99%
0.96
31.25%
1.54
60.82%
1.15
25.53%
1.11
3.21%
-0.11
110.28%
-2.72
2,284.72%
1.25
145.81%
intangibles to total assets
0.02
-
0.01
36.78%
0.01
15.06%
0.01
12.56%
0.01
2.62%
0.01
20.14%
0.01
10.87%
0.01
9.05%
0.03
194.93%
0.01
75.59%
0.01
1.23%
interest coverage
284.00
-
568.57
100.20%
1.30K
128.48%
3.93K
202.59%
996.74
74.64%
1.16K
16.08%
340.05
70.61%
516.83
51.99%
111.53
78.42%
-1.00
100.90%
interest debt per share
0.44
-
0.16
63.64%
-1.43
995.92%
-1.31
8.45%
-0.13
90.31%
0.36
386.98%
-0.05
113.25%
0.01
121.00%
0.10
914.33%
-0.51
593.53%
inventory turnover
1.52
-
1.55
1.67%
1.24
19.98%
1.48
19.02%
1.37
7.02%
1.51
10.33%
1.60
5.75%
1.40
12.58%
1.27
8.92%
1.34
5.44%
1.58
17.78%
invested capital
0.02
-
0.00
76.29%
-0.03
864.02%
-0.03
17.98%
-0.00
90.66%
0.01
398.76%
-0.00
116.78%
-0.00
53.15%
0.00
324.56%
-0.00
159.26%
market cap
4.91B
-
6.04B
22.91%
6.14B
1.57%
4.82B
21.50%
3.93B
18.38%
4.25B
7.99%
2.35B
44.56%
2.82B
19.72%
1.63B
42.22%
914.06M
43.87%
1.59B
73.64%
net current asset value
787.49M
-
1.19B
51.55%
1.63B
36.30%
1.78B
9.61%
1.67B
6.13%
1.26B
24.81%
1.30B
3.38%
759.42M
41.63%
872.97M
14.95%
931.77M
6.74%
1.30B
39.03%
net debt to ebitda
-0.43
-
-0.96
123.30%
-0.92
4.17%
-1.18
27.50%
-1.62
37.58%
-2.01
24.09%
-2.02
0.55%
-0.83
59.02%
-1.18
42.83%
-2.90
144.73%
-11.67
302.86%
net income per share
8.14
-
11.31
38.90%
12.63
11.71%
11.05
12.51%
5.26
52.41%
7.23
37.44%
6.35
12.13%
-10.49
265.15%
1.55
114.76%
0.68
56.27%
1.43
111.70%
operating cash flow per share
8.08
-
9.50
17.57%
9.23
2.86%
10.59
14.84%
8.06
23.91%
8.30
2.99%
7.06
14.94%
1.20
83.04%
-4.22
451.97%
0.84
120.04%
payables turnover
0.74
-
0.60
18.84%
0.70
16.08%
0.99
41.73%
7.72
678.40%
6.39
17.19%
8.49
32.80%
4.13
51.42%
3.93
4.70%
4.45
13.15%
7.26
63.19%
receivables turnover
2.52
-
1.82
27.69%
1.87
2.39%
1.87
0.19%
2.01
7.44%
2.35
16.85%
2.38
1.41%
2.06
13.61%
1.83
11.02%
2.21
20.65%
3.55
60.56%
research and ddevelopement to revenue
0.07
-
0.08
3.99%
0.07
1.41%
0.08
7.33%
0.11
32.43%
0.09
11.27%
0.09
1.79%
0.11
18.19%
0.10
11.33%
0.09
6.15%
0.10
12.49%
return on tangible assets
0.29
-
0.28
1.37%
0.25
11.13%
0.20
19.52%
0.09
56.47%
0.13
52.42%
0.11
21.07%
-0.17
259.42%
0.03
116.44%
0.01
56.62%
0.03
109.08%
revenue per share
17.15
-
20.15
17.48%
22.20
10.18%
21.29
4.08%
16.48
22.58%
17.18
4.23%
16.76
2.42%
14.37
14.30%
14.91
3.80%
15.24
2.22%
16.74
9.81%
roe
0.35
-
0.34
3.34%
0.28
18.34%
0.22
21.20%
0.10
56.62%
0.15
54.43%
0.12
21.49%
-0.24
302.62%
0.03
114.47%
0.01
56.82%
0.03
104.36%
roic
0.34
-
0.31
8.27%
0.28
10.06%
0.21
25.42%
0.10
52.44%
0.12
23.06%
0.10
21.14%
0.42
340.26%
0.08
81.01%
0.01
91.53%
sales general and administrative to revenue
0.09
-
0.10
-
0.15
46.10%
shareholders equity per share
22.94
-
32.96
43.70%
45.09
36.80%
50.06
11.03%
54.92
9.70%
48.87
11.01%
54.70
11.93%
44.59
18.49%
45.47
1.98%
46.05
1.29%
47.71
3.59%
stock based compensation to revenue
0.02
-
0.07
206.47%
-0.01
118.53%
-0.03
158.88%
0.05
260.13%
tangible asset value
996.73M
-
1.40B
40.16%
1.91B
36.55%
2.05B
7.30%
2.18B
6.63%
1.88B
13.78%
2.08B
10.59%
1.67B
19.82%
1.64B
1.74%
1.71B
4.52%
2.14B
24.70%
tangible book value per share
22.51
-
32.61
44.88%
44.54
36.55%
49.56
11.27%
54.35
9.67%
48.26
11.21%
54.11
12.12%
43.67
19.29%
43.56
0.25%
43.57
0.03%
56.85
30.50%
working capital
797.97M
-
1.20B
50.86%
1.63B
35.58%
1.79B
9.62%
1.68B
6.05%
1.27B
24.69%
1.31B
3.47%
794.53M
39.34%
905.77M
14.00%
950.88M
4.98%
942.30M
0.90%

All numbers in USD (except ratios and percentages)